Gary Meininger

16.0k citations
80 papers · 8.3k indexed · 8 hit papers · h-index 40

Gary Meininger

79 papers receiving 8.0k citations

Hit Papers

Effects of Canagliflozin on Fracture Risk in Pa...3372006202620122019200400600

Peers

Gary Meininger
Comparison fields: 5 of 110
  • Endocrinology, Diabetes and Metabolism 7.3k
  • Nephrology 639
  • Surgery 3.8k
  • Pharmacology 1.4k
  • Family Practice 123
Replace Hans J. Woerle with:
Hans J. Woerle Germany
Christian T. Ruff United States
Matthew A. Cavender United States
Michael G. Silverman United States
Greg Fulcher Australia
Paul S. Jellinger United States
Jaime A. Davidson United States
Dorothea Collins United States
Susan E. Manley United Kingdom
Michael Szarek United States
Gary Meininger relative to Hans J. Woerle Germany Hans J. Woerle's profile →
Citations per field
00.5×3.2×
Hans J. Woerle · 1×
Citations per year

Countries citing papers authored by Gary Meininger

Since Specialization
Citations

This map shows the geographic impact of Gary Meininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Meininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Meininger more than expected).

Fields of papers citing papers by Gary Meininger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Meininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Meininger. The network helps show where Gary Meininger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gary Meininger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Meininger Line = papers co-authored together Gary Meininger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20203
2 20185
3 2016263
4 201612
5 201655
6 20166
7 20167
8 201516
9 201547
10 20151
11
Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.
201416
12 201482
13 201439
14
Canagliflozin added on to dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 agonists with or without other antihyperglycaemic agents in type 2 diabetes mellitus
20130
15
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trialbreakdown →
2013406
16
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trialbreakdown →
2013606
17
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney diseasebreakdown →
2013418
18 2004103
19 200466
20 200267

About Gary Meininger

Gary Meininger is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Surgery, having authored 80 papers that have together received 8.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (68 papers), Pancreatic function and diabetes (45 papers), Diabetes Management and Research (35 papers), Pancreatitis Pathology and Treatment (11 papers), Metabolism, Diabetes, and Cancer (10 papers), Medication Adherence and Compliance (8 papers), HIV-related health complications and treatments (7 papers) and Bipolar Disorder and Treatment (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.3k citations), Nephrology (639 citations) and Surgery (3.8k citations). Gary Meininger has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include William Canovatchel, Keith Usiskin, Mehul Desai, William T. Cefalu, Dainius Balis, Ujjwala Vijapurkar, Kaj Stenlöf, Maria Alba, C. Tong and Vlado Perkovic. Their work appears in journals such as Canadian Journal of Diabetes, Diabetes Obesity and Metabolism, Current Medical Research and Opinion, Diabetes Care and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026